BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
CM
Canadian Imperial Bank of Commerce
There isn't enough reported data to score CM yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
CM's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like CM.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CM in the historical PE scenario, which offers more potential upside but is not a forecast.
CM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $69.03 | -41% |
| Fair | 11x | $80.72 | -30% |
| Expensive | 14x | $97.67 | -16% |
| Current | 16x | $116 | — |
Historical ranges are pointers, not guarantees.
CM's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
CM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CM, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
CM has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus CM up 27%.
CM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $7.09 | +27% |
| Q1 2026 | $6.74 | +25% |
| Q4 2025 | $6.03 | +18% |
| Q3 2025 | $5.82 | +20% |
| Q2 2025 | $5.59 | +21% |
| Q1 2025 | $5.41 | +18% |
| Q4 2024 | $5.12 | +41% |
| Q3 2024 | $4.87 | +42% |
CM's earnings per share have climbed steadily: $7.09 over the past year, up 27% from the year before, and higher year over year for 10 quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
CM has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 117% for CM.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
CM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $10.7B | +117% |
| Q1 2026 | $5.9B | +15% |
| Q4 2025 | $5.3B | +14% |
| Q3 2025 | $5.1B | +9.8% |
| Q2 2025 | $4.9B | +14% |
| Q1 2025 | $5.1B | +17% |
| Q4 2024 | $4.7B | +13% |
| Q3 2024 | $4.6B | +13% |
CM's revenue has grown year over year for 22 quarters in a row: $10.7B last quarter, up 117% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -16 points |
| Q1 2026 | 42% | +2.8 points |
| Q4 2025 | 37% | +0.5 points |
| Q3 2025 | 37% | +0.5 points |
| Q2 2025 | 37% | +2.1 points |
| Q1 2025 | 39% | +4 points |
| Q4 2024 | 36% | +4.5 points |
| Q3 2024 | 37% | +6 points |
CM's operating margin was 21% last quarter, down 16 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
CM Free Cash Flow
CM and BAC do not have enough comparable growth data to identify a winner.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -14M shares |
| 1 year | -2.7% | -25.3M shares |
| 3 years | +0.5% | +4.2M shares |
| 5 years | +2.1% | +18.7M shares |
| Available history | +2.9% | +25.6M shares |
CM has 917M diluted shares, down 2.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $625.7M |
| Q4 2025 | $527.3M |
| Q3 2025 | $210.9M |
| Q2 2025 | — |
| Q1 2025 | $210.9M |
| Q4 2024 | — |
| Q3 2024 | $457M |
| Q2 2024 | $228.5M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CM Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.1 | Neutral |
| Stochastic | 49.6 | Neutral |
CM's weekly RSI is 56 (neutral) and its Stochastic is 50 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over CM on valuation relative to its sector.
CM PE vs Financial Services Sector
| Metric | CM | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 26% above |
| PE % | 98 | 63 | 35 pts above |
CM is trading at 16x earnings, a 26% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.5 | 2.2% above |
| 20 week MA | $115.9 | 0.2% above |
| 50 week MA | $106.9 | 8.5% above |
| 100 week MA | $88.3 | 31% above |
| 200 week MA | $67.9 | 71% above |
CM has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.4 | $43.7 | +5.5% |
| 2021 | $43.7 | $58.0 | +33% |
| 2022 | $58.0 | $41.0 | -29% |
| 2023 | $41.0 | $48.1 | +17% |
| 2024 | $48.1 | $62.9 | +31% |
| 2025 | $62.9 | $93.0 | +48% |
| 2026 YTD | $93.0 | $116.0 | +25% |
CM has the edge over BAC on returns for 2026, with the stronger performance.